"Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with" by Matthew Hall, Yazmin Odia et al.

Menu

Skip to main content

All Publications

Matthew Hall, Miami Cancer InstituteFollow
Yazmin Odia, Miami Cancer InstituteFollow
Minesh Mehta, Miami Cancer InstituteFollow

Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

Publication Date

2019

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Journal of Neuro-Oncology (2019) 145(1):97-105

Restricted

Available to BHSF community via local IP address or BHSF login.

Find in your library

COinS